Rodriguez Javier 4
4 · DAVITA INC. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
DaVita (DVA) CEO Javier Rodriguez Receives Award
What Happened
- Javier Rodriguez, CEO of DaVita Inc. (DVA), was granted equity awards on March 15, 2026: 20,900 restricted stock units (RSUs) and 56,506 stock appreciation rights (SARs). Both grants are reported at $0.00 per share on the Form 4 (awards, transaction code A), so no cash was exchanged at grant.
Key Details
- Transaction date: March 15, 2026; Form 4 filed March 17, 2026 (appears timely under Form 4 rules).
- Grants reported at $0.00 per share (typical for awards); total reported acquisition value = $0.
- Shares owned after the transaction: Not specified in the filing.
- Footnotes:
- F1: The RSUs vest 50% on March 15, 2029 and 50% on March 15, 2030, subject to the award agreement.
- F2: The SARs vest 50% on March 15, 2029 and 50% on March 15, 2030, subject to the award agreement.
- No tax withholding sale or cashless exercise reported in this filing.
- Transaction code meaning: A = Award/Grant.
Context
- These awards are compensation grants, not open-market purchases or sales; they typically vest over time and are intended as long-term incentive pay. SARs are derivative awards that pay the holder the appreciation in the stock price (usually settled in cash or stock) upon exercise and subject to vesting/other terms. Such grants do not by themselves indicate an insider buying or selling shares on the open market.
Insider Transaction Report
Form 4
DAVITA INC.DVA
Rodriguez Javier
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1]2026-03-15+20,900→ 909,815 total - Award
Stock Appreciation Rights
[F2]2026-03-15+56,506→ 56,506 totalExercise: $150.72Exp: 2031-03-15→ Common Stock (56,506 underlying)
Footnotes (2)
- [F1]These restricted stock units are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement.
- [F2]The stock appreciation rights are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement.
Signature
/s/ Stephanie N. Berberich, Attorney-in-Fact|2026-03-17